Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin’s lymphoma
The immunotherapy of prostate and bladder cancer
Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells
Immune-related effects of local hyperthermia in patients with primary liver cancer
Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon
[Vaccine therapy of prostate cancer]
B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice
Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial
Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
[Current status of hyperthermia for therapy of brain tumor]
Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo
Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood
First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma
Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein
Immunotherapy in multiple myeloma–possibility or probability?
Dynamic control of lymphocyte trafficking by fever-range thermal stress